Zymeworks (ZYME) Tops Q4 EPS by 22c

Zymeworks (NYSE: ZYME) reported Q4 EPS of ($0.95), $0.22 better than the analyst estimate of ($1.17). Revenue for the quarter came in at $19.87 million versus the consensus estimate of $9.13 million.

For earnings history and earnings-related data on Zymeworks (ZYME) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04